Is Theriva Biologics, Inc. technically bullish or bearish?

Jun 25 2025 08:42 AM IST

share

Share Via

As of June 5, 2025, the trend is mildly bearish due to daily moving averages indicating bearish momentum, despite a mildly bullish weekly MACD and a bullish monthly RSI, resulting in mixed signals and underperformance against the S&P 500.

As of 5 June 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating bearish momentum, while the weekly MACD shows a mildly bullish signal. The monthly RSI is bullish, but the Bollinger Bands and KST on both weekly and monthly time frames are bearish. Overall, the mixed signals suggest a lack of strong bullish momentum, with the stock underperforming significantly against the S&P 500 across multiple time frames.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE

{{ moreButtonText }}

{{ dashverdictresult.dashboard.value < 10 ? '0' + dashverdictresult.dashboard.value : dashverdictresult.dashboard.value }}

Strong Sell

{{ dashverdictresult.dashboard.value < 10 ? '0' + dashverdictresult.dashboard.value : dashverdictresult.dashboard.value }}

Sell

{{ dashverdictresult.dashboard.value < 10 ? '0' + dashverdictresult.dashboard.value : dashverdictresult.dashboard.value }}

Hold

{{ dashverdictresult.dashboard.value < 10 ? '0' + dashverdictresult.dashboard.value : dashverdictresult.dashboard.value }}

Buy

{{ dashverdictresult.dashboard.value < 10 ? '0' + dashverdictresult.dashboard.value : dashverdictresult.dashboard.value }}

Strong Buy

{{i+1}}

{{key.head}}

{{li}}

{{dashverdictresult.dashboard.tab1_txt| uppercase}}

{{text.big_txt}}

{{text .small_txt}}

{{dashverdictresult.dashboard.stock_details.short_name}}

{{dashverdictresult.dashboard.stock_callafter}}

This is a Paid Feature

for MojoOne Subscribers

Click here to Get Started

Sign up to download verdict report

Sign up to download verdict report

{{loader_stocks[0]["loader_dw"]}}

SEND BY EMAIL

{{email_id_ver_err}}

{{dashverdictresult.dashboard.tab2_txt| uppercase}}

Register now to see if the stock’s characteristics match your investment style

Click here to Register

Click here to Register

Subscribe now to see if the stock's characteristics match your investment style

Click here to Get Started

{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}

{{ value[0] }}	{{ value[1] }}	{{ value[2] }}	{{ value[3] }}
{{ value[0] }}	{{ value[1] }}	{{ value[2] }}	{{ value[3] }}

{{dashverdictresult.dashboard.howMuchTabTxt|uppercase}}

Create your portfolio and know how much should this stock be in your portfolio

Click here to Create Portfolio

Subscribe now to know how much you should hold in this stock

Click here to Get Started

{{dashverdictresult.dashboard.tab3_txt| uppercase}}

We have found 2 better stocks that you can consider

Click here to view Switch options

Click here to view Switch options

RETURNS SUMMARY (Price + Dividend)

{{dashverdictresult.dashboard.return_text}}

Investors Returns (3 years) –

Period	6M	1Y	2Y	3Y
{{ keyd.val }}
{{ keyd.val }}

STOCK INFO & MOJO DOTS

Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}

Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}

Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}

Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}

Stock Info:

BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}

Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)

Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}

52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}

Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}

Related Stock Links

Our weekly and monthly stock recommendations are here

Stock of the Week

{{!sm.blur ? sm.comp_name : ''}}

Industry

{{sm.old_ind_name }}

Market Cap

{{sm.mcapsizerank }}

Date of Entry

{{sm.date }}

Entry Price

Target Price

{{sm.target_price }} ({{sm.performance_target }}%)

Holding Duration

{{sm.target_duration }}

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Week

Stock of the Month

{{sm.comp_name}} price as on {{sm.todays_date}}

₹{{sm.price_as_on}} ({{sm.performance}}%)

Industry

{{sm.old_ind_name}}

Market Cap

{{sm.mcapsizerank}}

Date of Entry

{{sm.date}}

Entry Price

{{sm.opening_price}}

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Month

Related News

Is Theriva Biologics, Inc. technically bullish or bearish?

Sep 20 2025 07:39 PM IST

share

Share Via

Who are in the management team of Theriva Biologics, Inc.?

Jun 22 2025 10:27 PM IST

share

Share Via

What does Theriva Biologics, Inc. do?

Jun 22 2025 06:36 PM IST

share

Share Via

How big is Theriva Biologics, Inc.?

Jun 22 2025 05:56 PM IST

share

Share Via

Most Read

Phoenix Intl. Sees Revision in Market Evaluation Amid Mixed Financial Signals

1 hour ago

share

Share Via

Dhanalaxmi Roto Sees Revision in Market Evaluation Amid Mixed Financial Signals

1 hour ago

share

Share Via

Sonu Infratech Sees Revision in Market Assessment Amid Mixed Financial Signals

1 hour ago

share

Share Via

Comfort Fincap Sees Revision in Market Evaluation Amid Mixed Financial Signals

1 hour ago

share

Share Via

Garg Furnace Sees Revision in Market Evaluation Amidst Mixed Financial Signals

1 hour ago

share

Share Via

Confidence Fut. Sees Revision in Market Assessment Amidst Challenging Financials

1 hour ago

share

Share Via

SVP Global Sees Revision in Market Assessment Amid Challenging Financials

1 hour ago

share

Share Via